Evaluation of methodologies to determine the effect of specific active immunotherapy on VEGF levels in phase I clinical trial patients with advanced solid tumors

Documenti analoghi

• Evaluation of methodologies to determine the effect of specific active immunotherapy on VEGF levels in phase I clinical trial patients with advanced solid tumors
  di: Sánchez Ramírez, Javier, et al.
  Pubblicazione: (2018)
• Characteristics of the specific humoral response in patients with advanced solid tumors after active immunotherapy with a VEGF vaccine, at different antigen doses and using two distinct adjuvants
  di: Sánchez Ramírez, Javier, et al.
  Pubblicazione: (2017)
• Specific humoral response in cancer patients treated with a VEGF-specific active immunotherapy procedure within a compassionate use program
  di: Sánchez Ramírez, Javier, et al.
  Pubblicazione: (2020)
• Does VEGF-targeted active immunotherapy induce complete abrogation of platelet VEGF levels?
  di: Sánchez Ramírez, Javier, et al.
  Pubblicazione: (2019)
• Mutated variant of human vascular endothelial growth factor as a vaccine candidate for cancer immunotherapy
  di: Mónica Bequet-Romero, et al.